keyword
https://read.qxmd.com/read/38582075/global-o-glycoproteome-enrichment-and-analysis-enabled-by-a-combinatorial-enzymatic-workflow
#1
JOURNAL ARTICLE
Taewook Kang, Rohit Budhraja, Jinyong Kim, Neha Joshi, Kishore Garapati, Akhilesh Pandey
A comprehensive analysis of site-specific protein O-glycosylation is hindered by the absence of a consensus O-glycosylation motif, the diversity of O-glycan structures, and the lack of a universal enzyme that cleaves attached O-glycans. Here, we report the development of a robust O-glycoproteomic workflow for analyzing complex biological samples by combining four different strategies: removal of N-glycans, complementary digestion using O-glycoprotease (IMPa) with/without another protease, glycopeptide enrichment, and mass spectrometry with fragmentation of glycopeptides using stepped collision energy...
April 1, 2024: Cell Rep Methods
https://read.qxmd.com/read/38577269/associations-of-urinary-fetuin-a-with-histopathology-and-kidney-events-in-biopsy-proven-kidney-disease
#2
JOURNAL ARTICLE
Ming-Tsun Tsai, Wei-Cheng Tseng, Kuo-Hua Lee, Chih-Ching Lin, Shuo-Ming Ou, Szu-Yuan Li
BACKGROUND: Fetuin-A is implicated in the pathogenesis of vascular calcification in chronic kidney disease (CKD); however, the relationship between fetuin-A, histopathologic lesions and long-term kidney outcomes in patients with various types of kidney disease remains unclear. METHODS: We measured urinary fetuin-A levels in 335 individuals undergoing clinically indicated native kidney biopsy. The expressions of fetuin-A mRNA and protein in the kidney were assessed using RNA sequencing and immunohistochemistry...
April 2024: Clinical Kidney Journal
https://read.qxmd.com/read/38541089/urinary-post-translationally-modified-fetuin-a-uptm-feta-in-chronic-kidney-disease-patients-with-and-without-diabetic-kidney-disease
#3
JOURNAL ARTICLE
Michela Musolino, Marta Greco, Mario D'Agostino, Loredana Tripodi, Roberta Misiti, Francesco Dragone, Paola Cianfrone, Mariateresa Zicarelli, Daniela Patrizia Foti, Michele Andreucci, Davide Bolignano, Giuseppe Coppolino
Background and Objectives: A novel post-translational modification (PTM) fragment derived from the cleavage of Fetuin-A (PTM-FetA) has recently emerged as a sensitive biomarker for kidney damage in diabetic patients, but evidence in other chronic renal diseases is lacking. In this pilot study, we aimed at evaluating the clinical significance of urinary PTM-FetA (uPTM-FetA) in a mixed cohort of patients with non-advanced chronic kidney disease (CKD) secondary to diabetic kidney disease (DKD) or other causes...
February 21, 2024: Medicina
https://read.qxmd.com/read/38510054/exercise-training-improves-diabetic-renal-injury-by-reducing-fetuin-a-oxidative-stress-and-inflammation-in-type-2-diabetic-rats
#4
JOURNAL ARTICLE
Shadan Saberi, Majid Askaripour, Mohammad Khaksari, Mohammad Amin Rajizadeh, Mohammad Abbas Bejeshk, Mohammad Akhbari, Elham Jafari, Kayvan Khoramipour
BACKGROUND: Diabetic kidney disease (DKD) stands as a primary contributor to end-stage renal disease, associated with heightened mortality in cardiovascular diseases. This study aimed to explore the impact of an eight-week high-intensity interval training (HIIT) on renal injury in diabetic rats. METHODS: Twenty-eight male Wistar rats were randomly allocated into four groups: healthy control (CTL), diabetic control (DC), exercise (EX), and diabetes-exercise (D + EX)...
March 30, 2024: Heliyon
https://read.qxmd.com/read/38487079/differential-associations-of-fetuin-a-and-calcification-propensity-with-cardiovascular-events-and-subsequent-mortality-in-patients-undergoing-hemodialysis
#5
JOURNAL ARTICLE
Katsuhito Mori, Tetsuo Shoji, Shinya Nakatani, Hideki Uedono, Akinobu Ochi, Hisako Yoshida, Yasuo Imanishi, Tomoaki Morioka, Yoshihiro Tsujimoto, Makoto Kuro-O, Masanori Emoto
BACKGROUND: Fetuin-A inhibits precipitation of calcium-phosphate crystals by forming calciprotein particles (CPP). A novel T50 test, which measures transformation time from primary to secondary CPP, is an index for calcification propensity. Both lower fetuin-A and shorter T50 levels were associated with cardiovascular disease (CVD) risk in patients with chronic kidney disease (CKD). Extremely high risk for CVD death in advanced CKD patients consists of high-incidental CVD event and high mortality after CVD event...
March 2024: Clinical Kidney Journal
https://read.qxmd.com/read/38481798/apigenin-targets-fetuin-a-to-ameliorate-obesity-induced-insulin-resistance
#6
JOURNAL ARTICLE
Man-Chen Hsu, Chia-Hui Chen, Mu-Chun Wang, Wen-Hua Chen, Po-An Hu, Bei-Chia Guo, Ru-Wen Chang, Chih-Hsien Wang, Tzong-Shyuan Lee
Fetuin-A, a hepatokine secreted by hepatocytes, binds to insulin receptors and consequently impairs the activation of the insulin signaling pathway, leading to insulin resistance. Apigenin, a flavonoid isolated from plants, has beneficial effects on insulin resistance; however, its regulatory mechanisms are not fully understood. In the present study, we investigated the molecular mechanisms underlying the protective effects of apigenin on insulin resistance. In Huh7 cells, treatment with apigenin decreased the mRNA expression of fetuin-A by decreasing reactive oxygen species-mediated casein kinase 2α (CK2α)-nuclear factor kappa-light-chain-enhancer of activated B activation; besides, apigenin decreased the levels of CK2α-dependent fetuin-A phosphorylation and thus promoted fetuin-A degradation through the autophagic pathway, resulting in a decrease in the protein levels of fetuin-A...
2024: International Journal of Biological Sciences
https://read.qxmd.com/read/38469141/serum-fetuin-a-and-risk-of-thoracic-aortic-aneurysms-a-two-sample-mendelian-randomization-study
#7
JOURNAL ARTICLE
Yang Chen, Jiayi Zhu, Xin Guo, Chenghui Cao, Xuan Xiao, Botao Zhu, Shuwei Weng, Die Hu, Yonghong Luo, Shuai Wang, Sha Wu, Jia He, Yang Yang, Daoquan Peng
BACKGROUND: Recent studies have revealed a significant decrease in serum fetuin-A levels in atherosclerotic aneurysms, indicating that fetuin-A may play a protective role in the progression of arterial calcification. However, the specific mechanism behind this phenomenon remains unclear. We aimed to examine the association between fetuin-A levels in thoracic aortic aneurysms (TAAs) and risk of TAAs and to evaluate whether this association was causal. METHODS: A total of 26 SNPs were selected as instrumental variables for fetuin-A in 9,055 participants of European ancestry from the CHARGE consortium, and their effects on thoracic aortic aneurysm and decreased descending thoracic aortic diameter were separately estimated in 353,049 and 39,688 individuals from FinnGen consortium...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38450510/prior-exposure-to-experimental-preeclampsia-increases-atherosclerotic-plaque-inflammation-in-atherogenic-mice-brief-report
#8
JOURNAL ARTICLE
Lauren A Biwer, Joshua J Man, Nicholas D Camarda, Brigett V Carvajal, S Ananth Karumanchi, Iris Z Jaffe
BACKGROUND: Women with a history of preeclampsia have evidence of premature atherosclerosis and increased risk of myocardial infarction and stroke compared with women who had a normotensive pregnancy. Whether this is due to common risk factors or a direct impact of prior preeclampsia exposure has never been tested in a mouse atherosclerosis model. METHODS: Pregnant LDLR-KO (low-density lipoprotein receptor knockout; n=35) female mice were randomized in midgestation to sFlt1 (soluble fms-like tyrosine kinase 1)-expressing adenovirus or identical control adenovirus...
April 2024: Arteriosclerosis, Thrombosis, and Vascular Biology
https://read.qxmd.com/read/38436186/biomarkers-of-diabetes-role-in-the-pathogenesis-of-atrial-fibrillation
#9
REVIEW
S Rafaqat, I Radoman Vujačić, S Gluscevic, S Sharif, A Klisic
The prevalence of both atrial fibrillation (AF) and diabetes is increasing day by day and commonly co-exist with a longer duration of diabetes and poor control, putting the individual at higher risk of AF. This review article presented some traditional and novel biomarkers related to AF in patients with diabetes mellitus. The literature review employed several databases, including Google Scholar, PubMed, and Science Direct. The investigation was finished on October 30, 2023. Many terms are utilized, including "AF", "Biomarkers", "Diabetes Mellitus", and "Pathogenesis"...
February 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38429385/the-effect-of-soy-isoflavones-on-non-alcoholic-fatty-liver-disease-and-the-level-of-fibroblast-growth-factor-21-and-fetuin-a
#10
JOURNAL ARTICLE
Asal Neshatbini Tehrani, Behzad Hatami, Bizhan Helli, Zahra Yari, Ghazal Daftari, Amin Salehpour, Mehdi Hedayati, Elmira Khalili, Seyed Ahmad Hosseini, Azita Hekmatdoost
A two-arm randomized open labeled controlled clinical trial was conducted on 50 patients with non-alcoholic fatty liver disease (NAFLD). Subjects were randomized to either receive two tablets of soy isoflavone (100 mg/day) or placebo. At week 12, the serum levels of alanine amino transferase (ALT), aspartate amino transferase (AST) and controlled attenuation parameter (CAP) score were significantly decreased only in the soy isoflavone group (P < 0.05). A significant decline in the gamma glutamyl transferase (GGT) level was observed only in the placebo group (P = 0...
March 1, 2024: Scientific Reports
https://read.qxmd.com/read/38404032/association-of-hepatokines-with-markers-of-endothelial-dysfunction-and-vascular-reactivity-in-obese-adolescents
#11
JOURNAL ARTICLE
David Stein, Daniela Ovadia, Stuart Katz, Preneet Cheema Brar
OBJECTIVES: Obesity-induced insulin resistance (IR) is known to influence hepatic cytokines (hepatokines), including fibroblast growth factor (FGF-21), fetuin-A, and chemerin. This study aimed to investigate the association between hepatokines and markers of endothelial dysfunction and vascular reactivity in obese adolescents. METHODS: A total of 45 obese adolescents were categorized into three groups based on glucose tolerance: normal glucose tolerance (NGT), prediabetes (PD), and type 2 diabetes (T2D)...
February 26, 2024: Journal of Pediatric Endocrinology & Metabolism: JPEM
https://read.qxmd.com/read/38402283/diabetes-mellitus-modifies-the-association-between-chronic-kidney-disease-mineral-and-bone-disorder-biomarkers-and-aortic-stiffness-in-peritoneal-dialysis-patients
#12
JOURNAL ARTICLE
Hsiang-Jung Huang, Bang-Gee Hsu, Chih-Hsien Wang, Jen-Pi Tsai, Yi-Hsin Chen, Szu-Chun Hung, Yu-Li Lin
This study aimed to investigate the relationship of four chronic kidney disease-mineral and bone disorder (CKD-MBD) biomarkers, including intact parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), soluble klotho, and fetuin-A, with aortic stiffness in peritoneal dialysis (PD) patients, comparing those with and without diabetes mellitus (DM). A total of 213 patients (mean age 58 ± 14 years; 81 (38.0%) patients with DM) were enrolled. Their aortic pulse wave velocity (PWV) was measured using pressure applanation tonometry, while serum intact PTH, FGF23, α-klotho, and fetuin-A levels were measured using enzyme-linked immunosorbent assay...
February 24, 2024: Scientific Reports
https://read.qxmd.com/read/38400238/simple-binding-and-dissociation-of-a-sialoglycoprotein-using-boronic-acid-modified-functional-interfaces-on-microparticles
#13
JOURNAL ARTICLE
Yukichi Horiguchi, Masato Yasuura, Hiroki Ashiba, Zheng Lin Tan, Takashi Fukuda
An overexpression of sialic acid is an indicator of metastatic cancer, and selective detection of sialic acid shows potential for cancer diagnosis. Boronic acid is a promising candidate for this purpose because of its ability to specifically bind to sialic acid under acidic conditions. Notably, the binding strength can be easily modulated by adjusting the pH, which allows for a simple dissociation of the bound sialic acid. In this study, we developed 5-boronopicolinic acid (5-BPA)-modified magnetic particles (BMPs) to selectively capture sialic acid biomolecules...
February 7, 2024: Sensors
https://read.qxmd.com/read/38395389/characterization-of-the-plasma-proteomic-profile-of-fabry-disease-potential-sex-and-clinical-phenotype-specific-biomarkers
#14
JOURNAL ARTICLE
Laura López-Valverde, María E Vázquez-Mosquera, Cristóbal Colón-Mejeras, Susana B Bravo, Sofía Barbosa-Gouveia, J Víctor Álvarez, Rosario Sánchez-Martínez, Manuel López-Mendoza, Mónica López-Rodríguez, Eduardo Villacorta-Argüelles, María A Goicoechea-Diezhandino, Francisco J Guerrero-Márquez, Saida Ortolano, Elisa Leao-Teles, Álvaro Hermida-Ameijeiras, María L Couce
Fabry disease (FD) is a X-linked rare lysosomal storage disorder caused by deficient α-galactosidase A (α-GalA) activity. Early diagnosis and the prediction of disease course are complicated by the clinical heterogeneity of FD, as well as by the frequently inconclusive biochemical and genetic test results that do not correlate with clinical course. We sought to identify potential biomarkers of FD to better understand the underlying pathophysiology and clinical phenotypes. We compared the plasma proteomes of 50 FD patients and 50 matched healthy controls using DDA and SWATH-MS...
February 21, 2024: Translational Research: the Journal of Laboratory and Clinical Medicine
https://read.qxmd.com/read/38386221/effect-of-intracerebroventricular-administration-of-galanin-like-peptide-on-hepatokines-in-c57bl-6%C3%A2-j-mice
#15
JOURNAL ARTICLE
Satoshi Hirako, Nobuhiro Wada, Yuzuru Iizuka, Takahiro Hirabayashi, Haruaki Kageyama, Hyounju Kim, Naoko Kaibara, Naoko Yanagisawa, Fumiko Takenoya, Seiji Shioda
Galanin-like peptide (GALP) is a neuropeptide that was first isolated and identified from the porcine hypothalamus. Studies have described an anti-obesity effect of GALP. We previously found that intracerebroventricular administration of GALP in mice resulted in an increase in respiratory exchange rate 12 to 16 h later. GALP may also affect glucose metabolism, but the detailed mechanism has not been elucidated. In this study, we investigated the effects of GALP on glucose and lipid metabolism in the liver...
February 22, 2024: Journal of Molecular Neuroscience: MN
https://read.qxmd.com/read/38365278/serum-biomarker-signature-is-predictive-of-the-risk-of-hepatocellular-cancer-in-patients-with-cirrhosis
#16
JOURNAL ARTICLE
Hashem El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
BACKGROUND: Inflammatory and metabolic biomarkers have been associated with hepatocellular cancer (HCC) risk in phases I and II biomarker studies. We developed and internally validated a robust metabolic biomarker panel predictive of HCC in a longitudinal phase III study. METHODS: We used data and banked serum from a prospective cohort of 2266 adult patients with cirrhosis who were followed until the development of HCC (n=126). We custom designed a FirePlex immunoassay to measure baseline serum levels of 39 biomarkers and established a set of biomarkers with the highest discriminatory ability for HCC...
February 16, 2024: Gut
https://read.qxmd.com/read/38332320/plasma-proteome-analysis-and-validation-of-patients-with-community-acquired-pneumonia-a-cohort-study
#17
JOURNAL ARTICLE
Lili Zhao, Wenjie Bian, Ying Shang, Hui Zhi, Xinqian Ma, Yukun He, Wenyi Yu, Chunyu Liu, Yu Xu, Pihua Gong, Zhancheng Gao
PURPOSE: This study aimed to investigate the diagnostic potential of plasma biomarkers of community-acquired pneumonia (CAP) and their severity grading. EXPERIMENTAL DESIGN: Plasma proteomes from cohort I (n = 32) with CAP were analyzed by data-independent acquisition mass spectrometry (MS). MetaboAnalyst 5.0 was used to statistically evaluate significant differences in proteins from different samples, and demographic and clinical data were recorded for all enrolled patients...
February 8, 2024: Proteomics. Clinical Applications
https://read.qxmd.com/read/38315202/association-of-pro-inflammatory-cytokines-adipokines-and-hepatokine-with-incident-diabetes-in-india-a-nested-case-control-study-within-carrs-cohort
#18
JOURNAL ARTICLE
Ruby Gupta, Roopa Shivashankar, Dimple Kondal, Kuppan Gokulakrishnan, Shivani A Patel, Mohammed K Ali, K M Venkat Narayan, Viswanathan Mohan, Nikhil Tandon, Dorairaj Prabhakaran
AIMS: To study the association of pro-inflammatory markers with incident diabetes in India. METHODS: We did a nested case-control study within the CARRS (Centre for Ardiometabolic Risk Reduction in South Asia) cohort. Of the 5739 diabetes-free individuals at the baseline, 216 participants with incident diabetes and 432 age-, gender- and city-matched controls at 2-year follow-up were included. We measured high sensitive C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 ( MCP-1), adiponectin, leptin and fetuin-A in the stored baseline blood samples...
February 5, 2024: Acta Diabetologica
https://read.qxmd.com/read/38296116/vildagliptin-inhibits-high-fat-and-fetuin-a-mediated-dpp-4-expression-intracellular-lipid-accumulation-and-insulin-secretory-defects-in-pancreatic-beta-cells
#19
JOURNAL ARTICLE
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Tanmay Majumdar, Satinath Mukhopadhyay, Rakesh Kundu
Dipeptidyl peptidase-4 (DPP-4), a ubiquitous proteolytic enzyme, inhibits insulin secretion from pancreatic beta cells by inactivating circulating incretin hormones GLP-1 and GIP. High circulating levels of DPP-4 is presumed to compromise insulin secretion in people with type 2 diabetes (T2D). Our group recently reported lipid induced DPP-4 expression in pancreatic beta cells, mediated by the TLR4-NF-kB pathway. In the present study, we looked at the role of Vildagliptin on pancreatic DPP-4 inhibition, preservation of islet mass and restoration of insulin secretion...
January 29, 2024: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/38290234/adipocytokines-levels-as-potential-biomarkers-for-discriminating-patients-with-a-diagnosis-of-depressive-disorder-from-healthy-controls
#20
JOURNAL ARTICLE
Elżbieta Małujło-Balcerska, Tadeusz Pietras
BACKGROUND: Depressive disorder is a complex mental health condition in which the etiopathogenesis involves several factors. Suitable biomarkers for the development of depression have not yet been established. Alterations in cytokines are assumed to be involved in the pathophysiology of depressive disorder. Adipokines (also known as adipocytokines) are important factors that not only regulate the energy balance but also regulate the inflammatory and immune responses. This study investigated the serum levels of adiponectin, leptin, resistin, chemerin, and fetuin A and the possible role of these adipokines in depressive disorder...
January 20, 2024: Journal of Psychiatric Research
keyword
keyword
60503
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.